Cereno Scientific publishes the interim report for Q1 2024 ( January 1–March 31)
The Board and Chief Executive Officer of Cereno Scientific AB here present the interim report for Q1 2024 ( January 1–March 31).Summary of the interim report for Q1 2024 ( January 1–March 31) Cereno Scientific Group · Net Sales were SEK 0 (0) · Result after financial items was SEK -15,437,724 (-4,409,588) · Earnings per share was SEK -0.07 (-0.03) before dilution and SEK -0.05 (-0.03) after dilution · The equity/assets ratio was 74.5% (94.3%) · Cash and bank balance was SEK 49,178,602 SEK (44,622,145) Parent company · Net Sales were SEK 0 (0) · Result after